tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO
US Market

Crescent Biopharma (CBIO) Cash flow

Compare
1,022 Followers

Crescent Biopharma Cash Flow

CBIO's free cash flow for Q4 2025 was $22.13M. For the 2025 fiscal year, CBIO's free cash flow was decreased by $-41.34M and operating cash flow was $22.21M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -71.53M$ -31.10M$ -34.88M$ -46.46M$ -57.49M
Investing Cash Flow
$ -72.92M$ 20.03K$ -21.39K$ -84.19K$ -14.94K
Financing Cash Flow
$ 322.98M$ 5.40K$ 28.82M$ 4.16M$ 10.72M
End Cash Position
$ 213.30M$ 10.72M$ 41.79M$ 47.87M$ 90.25M
Free Cash Flow
$ -72.45M$ -31.11M$ -34.90M$ -46.54M$ -57.50M
Currency in USD

Crescent Biopharma Cash Flow